In this study, we investigated neurodegenerative manifestations in the MS animal model, chronic MOG 35–55 peptide induced EAE, in which axonal and neuronal pathologies are prevalent [9,10,11]. The gene discussed is MOG; the disease is myeloid sarcoma.